Tags: lap | band | surgery | FDA | advertisement | ads | billboards

FDA Targets Ads for Lap-Band Surgery

Wednesday, 14 Dec 2011 10:04 PM


The U.S. Food and Drug Administration warned against misleading ads by eight surgical centers and a marketing firm.

By failing to provide the required side effects and surgical risk information about Lap-Band procedures – and in a font size big enough to be legible – the firms face penalties and inventory seizure, the FDA said.

Allergan, Inc.’s Lap-Band is considered a restricted medical device. The procedure involves surgically inserting an inflatable gastric band at the top of the stomach to reduce stomach capacity. It is approved to help obese patients lose weight when methods such as diet and exercise fail. More than a third of American adults are obese.

Risks of the Lap-Band procedure include infection, nausea, vomiting and irritation of the esophagus.

The centers receiving the FDA’s warning were Bakersfield Surgery Institute, Inc., Beverly Hills Surgery Center, Palmdale Ambulatory Center, Valley Surgical Center, Top Surgeons LLC, Valencia Ambulatory Center LLC, Cosmopolitan Plastic & Reconstructive Surgery and San Diego Ambulatory Center LLC, and 1-800-GET-THIN.


© HealthDay

   
1Like our page
2Share
Health-Wire
Eight surgical centers have failed to provide the required risk information --in a font size big enough to be legible, the FDA said.
lap,band,surgery,FDA,advertisement,ads,billboards,risks
164
2011-04-14
Wednesday, 14 Dec 2011 10:04 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved